Abstract
In patients with AIDS, the most important ocular opportunistic infection, CMV retinitis, can now be treated effectively with virostatic agents. Associated retinal detachment is encountered frequently, and its management has become increasingly significant to quality of life as improvements in medical care have helped to preserve vision and extend life expectancy. Although retinal detachment in these eyes is typically rhegmatogenous, the pathophysiology is distinctive due to the association with CMV retinitis which, even in remission, is characterised by atrophic changes at all levels of affected retina and alterations of the vitreous. Despite initially successful surgical reattachment, multiple, small, often posterior holes may develop because of progressive CMV infection. For these reasons, vitrectomy and silicone oil injection with scleral buckling may currently provide the best overall means of maintaining retinal reattachment and restoring visual function. Nevertheless, management must be individualised in each case, with the realisation that progressive visual loss frequently ensues from retinitis progression.
Similar content being viewed by others
Article PDF
References
Friedman AH, Orellana J, Freeman WR et al: Cytomegalovirus retinitis: a manifestation of the acquired immune deficiency syndrome (AIDS). Br J Ophthalmol 1983, 67: 372–80.
Holland GN, Pepose JS, Pettit TH et al: Acquired immune deficiency syndrome. Ocular manifestations. Ophthalmol 1983, 90: 859–73.
Freeman WR, Lerner CW, Mines JA et al: A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome. Am J Ophthalmol 1984, 97: 133–42.
Jabs DA, Enger C, Bartlett JG : Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol 1989, 107: 75–80.
Gross JG, Bozzette SA, Mathews WC et al: Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmol 1990, 97: 681–6.
Henderly DE, Freeman WR, Causey DM et al: Cytomegalovirus retinitis and response to therapy with gancic1ovir. Ophthalmol 1987, 94: 425–34.
Holland GN, Sidikaro Y, Kreiger AE et al: Treatment of cytomegalovirus retinopathy with gancic1ovir. Ophthalmol 1987, 94: 815–23.
Pepose JS, Newman C, Bach MC et al: Pathologic features of cytomegalovirus retinopathy after treatment with the antiviral agent gancic1ovir. Ophthalmol 1987, 94: 414–24.
LeHoang P, Girard B, Robinet M et al: Foscamet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmol 1989, 96: 865–74.
Fabricius EM, Holzer E, Prant F : Experiences with DHPG (gancic1ovir)—treatment of cytomegalovirus retinitis in AIDS. Fortschr Ophthalmol 1989, 86: 124–8.
Freeman WR, Henderly DE, Wan WL et al: Prevalence, pathophysiology, and treatment of rhegmatogenous retinal detachment in treatment cytomegalovirus retinitis. Am J Ophthalmol 1987, 103: 527–36.
Sidikaro Y, Silver L, Holland GN et al: Rhegmatogenous retinal detachments in patients with AIDS and necrotising retinal infections. Ophthalmol 1991, 98: 129–35.
Orellana J, Teich SA, Lieberman RM et al: Treatment of retinal detachments in patients with the acquired immune deficiency syndrome. Ophthalmol 1991, 98: 939–43.
Jabs DA, Enger C, Haller J et al: Retinal detachments in patients with cytomegalovirus retinitis. Arch Ophthalmol 1991, 109: 794–9.
Hilton GF and Grizzard WS : Pneumatic retinopexy: a two-step outpatient operation without conjunctival incision. Ophthalmol 1986, 93: 626–41.
Mondino BJ, Sidikaro Y, Mayer FJ et al: Inflammatory mediators in the vitreous humor of AIDS patients with retinitis. Invest Ophthalmol Vis Sci 1990, 31: 798–804.
Foulds WS : Is your vitreous really necessary? The role of the vitreous in the eye with particular reference to retinal attachment, detachment and the mode of action of vitreous substitutes. Eye 1987, 1: 641–64.
Holland GN, Buhles WC, Mastre B et al: A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardised system for the assessment of disease outcome. Arch Ophthalmol 1989, 107: 1759–66.
Blumenkranz M, Clarkson J, Culbertson WW et al: Visual results and complications after retinal reattachment in the acute retinal necrosis syndrome. Retina 1989, 9: 170–74.
Kreiger AE : Management of combined inflammatory and rhegmatogenous retinal detachments (ARN and AIDS). In Ryan SJ ed. Retina, St. Louis: CV Mosby 1989: 591–8.
Irvine AR . Treatment of rhegmatogenous retinal detachment in AIDS patients with cytomegalovirus retinitis. Trans Am Ophthalmol Soc, (in press).
Henderly DE, Freeman WR, Smith RE et al: Cytomegalovirus retinitis as the initial manifestation of the acquired immune deficiency syndrome. Am J Ophthalmol 1987, 103: 316–20.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chuang, E., Davis, J. Management of retinal detachment associated with CMV retinitis in aids patients. Eye 6, 28–34 (1992). https://doi.org/10.1038/eye.1992.4
Issue Date:
DOI: https://doi.org/10.1038/eye.1992.4
Keywords
This article is cited by
-
Un-explained visual loss following silicone oil removal: results of the Pan American Collaborative Retina Study (PACORES) Group
International Journal of Retina and Vitreous (2017)
-
Management of viral retinitis-associated retinal detachment in AIDS
Eye (1997)